pancuronium 2 mg/ml solution for injection
hospira uk limited - pancuronium bromide - solution for injection - 2 mg/ml - other quaternary ammonium compounds
pancuronium bromide 2 mg/ml solution for injection
pfizer healthcare ireland - pancuronium bromide - solution for injection - 2 milligram(s)/millilitre - other quaternary ammonium compounds; pancuronium
norcuron 4mg powder for injection ampoule
merck sharp & dohme australia pty ltd - vecuronium bromide -
vecure
viatris limited - vecuronium bromide 10mg - powder for injection - 10 mg - active: vecuronium bromide 10mg excipient: citric acid dibasic sodium phosphate mannitol phosphoric acid sodium hydroxide - vecure is indicated as an adjunct to general anaesthesia to facilitate tracheal intubation and to provide skeletal muscle relaxation during surgery.
pancuronium bromide injection bp
pancuronium bromide -
norcuron
merck sharp & dohme (new zealand) limited - vecuronium bromide 10mg - powder for injection - 10 mg - active: vecuronium bromide 10mg excipient: citric acid monohydrate dibasic sodium phosphate mannitol - norcuron is indicated as an adjunct to general anaesthesia to facilitate tracheal intubation and to provide skeletal muscle relaxation during surgery.
norcuron
merck sharp & dohme (new zealand) limited - vecuronium bromide 4mg - powder for injection - 4 mg - active: vecuronium bromide 4mg excipient: citric acid monohydrate dibasic sodium phosphate mannitol water for injection - norcuron is indicated as an adjunct to general anaesthesia to facilitate tracheal intubation and to provide skeletal muscle relaxation during surgery.
rocuronium bromide- rocuronium bromide injection
mylan institutional llc - rocuronium bromide (unii: i65mw4ofhz) (rocuronium - unii:wre554rfez) - rocuronium bromide 10 mg in 1 ml - rocuronium bromide injection is indicated for inpatients and outpatients as an adjunct to general anesthesia to facilitate both rapid sequence and routine tracheal intubation, and to provide skeletal muscle relaxation during surgery or mechanical ventilation. rocuronium bromide injection is contraindicated in patients known to have hypersensitivity (e.g., anaphylaxis) to rocuronium bromide or other neuromuscular blocking agents [see warnings and precautions (5.2)] . developmental toxicology studies have been performed with rocuronium bromide in pregnant, conscious, nonventilated rabbits and rats. inhibition of neuromuscular function was the endpoint for high-dose selection. the maximum tolerated dose served as the high-dose and was administered intravenously 3 times a day to rats (0.3 mg/kg, 15% to 30% of human intubation dose of 0.6 to 1.2 mg/kg based on the body surface unit of mg/m2 ) from day 6 to 17 and to rabbits (0.02 mg/kg, 25% human dose) from day 6 to 18 of pregnancy. high-dose treatment caused acut
pancuronium 4 mg/ml solution for injection
mercury pharmaceuticals (ireland) ltd - pancuronium bromide - solution for injection - 4 mg/ml
rocon rocuronium bromide 100 mg/10 ml solution for injection vial
medis pharma pty ltd - rocuronium bromide, quantity: 100 mg - injection, solution - excipient ingredients: acetic acid; sodium hydroxide; sodium chloride; water for injections; sodium acetate trihydrate - adjunct to general anaesthesia to facilitate endotracheal intubation during routine induction, to provide muscle relaxation and to facilitate mechanical ventilation in adults, children and infants over 1 month of age.. adjunct to general anaesthesia to facilitate endotracheal intubation during rapid sequence induction when suxamethonium is contraindicated, however, this has not been studied in infants and children. rocuronium is also indicated as an adjunct in the intensive care unit (icu) to facilitate mechanical ventilation.